Purpose

This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 75 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Mass General Brigham primary care patient - Age 18-75 - Clinically significant symptoms of depression (Patient Health Questionnaire-9 (PHQ-9) greater than or equal to 10) and/or anxiety (Generalized Anxiety Disorder-7 (GAD-7) greater than or equal to 8) - Owns a smartphone capable of running the study applications - Fluent in English.

Exclusion Criteria

  • Diagnosis of bipolar I or bipolar II disorder per patient report or the patient's medical record - Diagnosis of any psychotic disorder per patient report or the patient's medical record - Current substance use disorder per patient report or the patient's medical record - Acute and/or unstable medical problem that may interfere with participation (e.g., scheduled for surgery in the next two months).

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial Assignment
Intervention Model Description
2x2 factorial trial with micro-randomization in automated motivational messaging arms
Primary Purpose
Health Services Research
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
IntelliCare with Automated Motivational Messaging and Coach Support
IntelliCare Plus mobile application intervention with two engagement strategies, automated motivational messaging and coach support.
  • Behavioral: IntelliCare Plus
    Mobile-app-based digital mental health intervention for individuals struggling with depression and/or anxiety. The app reflects components of evidence-based psychological treatments such as cognitive-behavioral therapy.
Experimental
IntelliCare with Automated Motivational Messaging
IntelliCare Plus mobile application intervention with one engagement strategy, automated motivational messaging.
  • Behavioral: IntelliCare Plus
    Mobile-app-based digital mental health intervention for individuals struggling with depression and/or anxiety. The app reflects components of evidence-based psychological treatments such as cognitive-behavioral therapy.
Experimental
IntelliCare with Coach Support
IntelliCare Plus mobile application intervention with one engagement strategy, coach support.
  • Behavioral: IntelliCare Plus
    Mobile-app-based digital mental health intervention for individuals struggling with depression and/or anxiety. The app reflects components of evidence-based psychological treatments such as cognitive-behavioral therapy.
Active Comparator
IntelliCare Alone
IntelliCare Plus mobile application intervention with no additional engagement strategy applied.
  • Behavioral: IntelliCare Plus
    Mobile-app-based digital mental health intervention for individuals struggling with depression and/or anxiety. The app reflects components of evidence-based psychological treatments such as cognitive-behavioral therapy.

Recruiting Locations

More Details

Status
Recruiting
Sponsor
Brigham and Women's Hospital

Study Contact

Jessica M Lipschitz, PhD
6177326548
jlipschitz@bwh.harvard.edu

Detailed Description

This 8-week, clinical trial involves primary care patients with clinically significant depression and/or anxiety recruited via provider referral. Participants will received access to a digital mental health intervention with known efficacy and be randomized to an engagement strategy condition--a previously-validated Coach Support protocol (CS), a newly-developed automated motivational messaging protocol (AMM), both or neither. To further understand how messages in the AMM arms function, message delivery will be micro-randomized: each day participants will be randomized to receive a message or not, such that they receive an average of 4.2 messages/week. Micro-randomization allows causal inference about the near-term impact of message delivery (i.e., are AMMs a cue to action) and the relationship between message impact and context (e.g., day in study). Measured outcome data will include level of engagement (operationalized as minutes of intervention use) and weekly self-reports of clinical outcomes.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.